Elisabetta Magnaterra, Mattia Giovannini, Cesare Filippeschi, Fausto Andrea Pedaci, Greta Tronconi, Michele Callea, Silvia Ricci, Francesca Mori, Maria Parpagnoli, Teresa Oranges
Trichothiodystrophy (TTD) is a rare congenital disorder caused by genetic mutations, leading to hair and skin abnormalities. We report successful treatment of a TTD case using dupilumab, a monoclonal antibody targeting IL-4Rα. The patient, a 7-year-old boy, exhibited significant improvement in skin and hair conditions, suggesting the potential of dupilumab as a therapeutic option for TTD. Further research is needed to elucidate its mechanism and efficacy in TTD treatment.
April 16, 2024: Pediatric Dermatology